Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia
| Errataetall: |
CommentIn: Eur J Endocrinol. 2020 Dec;183(6):L29-L30. - PMID 33105103 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:183 |
|---|---|
| Enthalten in: |
European journal of endocrinology - 183(2020), 6 vom: 18. Dez., Seite L27-L28 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sarafoglou, Kyriakie [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 17.11.2020 Date Revised 10.02.2021 published: Print CommentIn: Eur J Endocrinol. 2020 Dec;183(6):L29-L30. - PMID 33105103 Citation Status MEDLINE |
|---|
| doi: |
10.1530/EJE-20-0938 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316739197 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316739197 | ||
| 003 | DE-627 | ||
| 005 | 20231225161731.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1530/EJE-20-0938 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1055.xml |
| 035 | |a (DE-627)NLM316739197 | ||
| 035 | |a (NLM)33105100 | ||
| 035 | |a (PII)EJE-20-0938 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sarafoglou, Kyriakie |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hydrocortisone suspension formulations are not necessarily the same in the treatment of children with congenital adrenal hyperplasia |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 17.11.2020 | ||
| 500 | |a Date Revised 10.02.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a CommentIn: Eur J Endocrinol. 2020 Dec;183(6):L29-L30. - PMID 33105103 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Hydrocortisone |2 NLM | |
| 650 | 7 | |a WI4X0X7BPJ |2 NLM | |
| 700 | 1 | |a Jaber, Mutaz M |e verfasserin |4 aut | |
| 700 | 1 | |a Al-Kofahi, Mahmoud |e verfasserin |4 aut | |
| 700 | 1 | |a Brundage, Richard C |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t European journal of endocrinology |d 1996 |g 183(2020), 6 vom: 18. Dez., Seite L27-L28 |w (DE-627)NLM074863665 |x 1479-683X |7 nnns |
| 773 | 1 | 8 | |g volume:183 |g year:2020 |g number:6 |g day:18 |g month:12 |g pages:L27-L28 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1530/EJE-20-0938 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 183 |j 2020 |e 6 |b 18 |c 12 |h L27-L28 | ||